Cointime

Kalypsys

company

About

Kalypsys provides drug discovery and development services.

  • 101 - 250

Highlights

Total Funding Amount
$29M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$29M
Industries
Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 2001
Number Of Employee
101 - 250
Operating Status
Active

Kalypsys provides pathway-based drug discovery and development services. The company implements discovery programs across a broad number of therapeutic areas using its automated and integrated suite of discovery technologies in biology, chemistry and informatics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$29M
Kalypsys has raised a total of $29M in funding over 2 rounds. Their latest funding was raised on Aug 5, 2004 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 5, 2004 Series B $29M 1 Invemed Catalyst Fund — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Kalypsys is funded by 1 investors. Invemed Catalyst Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Invemed Catalyst Fund Yes Series B
Cointime
เนื้อหา
บริษัท